Reaktion #69721

ord-95298a64fa804811841f4fa40bbed8ba

Reaktionsbedingungen

Temperatur
135°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Waschenwashed with saturated NaHCO3
  2. 2
    Trocknendried (MgSO4)
  3. 3
    Sonstigeevaporated
  4. 4
    SonstigePurification by flash column chromatography (Biotage SP4-25 S, 25 ml/min)
  5. 5
    Wascheneluting with 1:3
  6. 6
    SonstigeEvaporation of product
  7. 7
    workup.ADDITIONcontaining fractions

Vorschrift

A mixture of (2,4-bis-benzyloxy-5-isopropenyl-phenyl)-(5-bromo-1,3-dihydro-isoindol-2-yl)-methanone (240 mg, 0.43 mmol), t-butyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine carboxylate (210 mg, 1.25 equiv.), bis(tri-t-butylphosphine)palladium(0) (12.5 mg, 2.5 mol %) and potassium carbonate (350 mg, 6 equiv.) in toluene/water/ethanol (1 ml: 1 ml: 4 ml) was heated at 135° C. for 30 minutes in a CEM explorer microwave synthesiser. The reaction mixture was diluted with EtOAc, washed with saturated NaHCO3, dried (MgSO4) and evaporated. Purification by flash column chromatography (Biotage SP4-25 S, 25 ml/min) eluting with 1:3 then 1:1 EtOAc/P.E. Evaporation of product containing fractions gave 85 mg of 4-{4-[2-(2,4-bis-benzyloxy-5-isopropenyl-benzoyl)-2,3-dihydro-1H-isoindol-5-yl]-phenyl}piperazine-1-carboxylic acid tert-butyl ester. MS: [M+H]+ 736.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08530469B2uspto-grants-2013_09